Biotech & Health Tech

Heron sells assets to CorMedix for $145M upfront; Faeth's stock tumbles

Endpoints News (Biopharma) · Nov 9, 2026 — 22:13 · 2 views · Original article ↗

Plus, news about Immunovant, Abeona Therapeutics, Ellodi Pharmaceuticals, Spruce Biosciences, Adrenyx Biosciences, Edesa Biotech, Kyorin Pharmaceutical, Charles River Laboratories, Frontage, Compass Pathways, Johnson & Johnson, Veradermics and Valneva. CorMedix acquires Heron portfolio: CorMedix

This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗

Ready to grow your traffic?

Run a free SEO audit of your website in under 60 seconds — no account required.

Get Your Free SEO Audit Explore Our Services